Document is current
Any future updates will be listed below
-
Authors
Kar, Sudeshna Sil
Cetin, Hasan
Abraham, Joseph
Srivastava, Sunil K.
Madabhushi, Anant
Ehlers, Justis P.
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01CA249992, R01CA202752, R01CA208236, R01CA216579, R01CA220581, R01CA257612, R01CA268207A1, U01CA239055, U01CA248226, U54CA254566)
National Heart, Lung and Blood Institute (R01HL151277, R01HL158071)
National Institute of Biomedical Imaging and Bioengineering (R43EB028736)
National Center for Research Resources (C06 RR12463-01)
United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service (VA Merit Review Award IBX004121A)
Office of the Assistant Secretary of Defense for Health Affairs (Breast Cancer Research Program (W81XWH-19-1-0668), the Prostate Cancer Research Program (W81XWH-15-1-0558, W81XWH-20-1-0851), the Lung Cancer Research Program (W81XWH-18-1-0440, W81XWH-20-1-0595), the Peer Reviewed Cancer Research Program (W81XWH-18-1-0404, W81XWH-21-1-0345), the Kidney Precision Medicine Project (KPMP) Glue Grant and sponsored research agreements from Bristol Myers-Squibb, Boehri)
NIH-NEI P30 Core Gran (IP30EY025585)
Unrestricted Grants from The Research to Prevent Blindness, Inc (Cole Eye Institute), Cleveland Eye Bank Foundation awarded to the Cole Eye Institute (IP30EY025585)
- License Information
-
More Information
Article History
Received: 12 March 2023
Accepted: 22 July 2024
First Online: 30 July 2024
Competing interests
: Dr. Srivastava has research support from Regeneron, Allergan, and Gilead; is a consultant for Bausch and Lomb, Novartis, and Regeneron. Dr. Madabhushi has research Funding: Astrazeneca, Bristol Myers-Squibb, Boehringer-Ingelheim, Eli-Lilly. Equity: Picture Health Inc, Inspirata Inc., Elucid Bioimaging, Consultant: Aiforia, Caris, Roche, Biohme, Castle Biosciences, Simbiosys. Dr. Ehlers has research support from the following: Aerpio, Alcon, Thrombogenics/Oxurion, Regeneron, Genentech, Novartis, Allergan, Apellis, Iveric, Stealth, Perceive Biotherapeutics, Roche, Alexion; is a consultant for the following: Aerpio, Adverum, Alcon, Allegro, Allergan, Genentech/Roche, Stealth, Novartis, Thrombogenics/Oxurion, Leica, Zeiss, Regeneron, Santen, Perceive Biotherapeutics, Boerhinger-Ingelheim, Exegenesis, RegenxBIO, Roche, Alexion; and holds a patent with Leica. Dr. Sil Kar, Dr. Cetin and Dr. Abraham have no financial disclosures to report.
